Essex Bio-Technology Ltd
HKEX:1061
Essex Bio-Technology Ltd
Cash from Financing Activities
Essex Bio-Technology Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Essex Bio-Technology Ltd
HKEX:1061
|
Cash from Financing Activities
-HK$309.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H
|
Hbm Holdings Ltd
HKEX:2142
|
Cash from Financing Activities
$70.6m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
Cash from Financing Activities
HK$2.9m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Uni-Bio Science Group Ltd
HKEX:690
|
Cash from Financing Activities
HK$4.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
CK Life Sciences Intl (Holdings) Inc
HKEX:775
|
Cash from Financing Activities
-HK$596.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
See Also
What is Essex Bio-Technology Ltd's Cash from Financing Activities?
Cash from Financing Activities
-309.9m
HKD
Based on the financial report for Dec 31, 2023, Essex Bio-Technology Ltd's Cash from Financing Activities amounts to -309.9m HKD.
What is Essex Bio-Technology Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-83%
Over the last year, the Cash from Financing Activities growth was -83%.